In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma
Conditions: Pheochromocytoma; Paraganglioma Intervention: Drug: [18F]FluorThanatrace ([18F]FTT) Sponsor: Heather Wachtel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials